Blar i Publikasjoner fra Cristin - St. Olavs hospital på tidsskrift "Neoplasia"
Viser treff 1-1 av 1
-
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
(Peer reviewed; Journal article, 2018)Glioblastoma (GBM) is the most aggressive primary brain tumor with a median survival of less than 15 months, emphasizing the need for better treatments. Immunotherapy as a treatment for improving or aiding the patient’s ...